clarithromycin has been researched along with Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiya, H; Hamada, K; Hamaguchi, S; Hori, Y; Morii, E; Okuno, H; Tanaka, H; Tomono, K; Yoshida, H; Yoshikawa, H | 1 |
| Evan, G; Jokinen, CH; Yeh, I | 1 |
2 other study(ies) available for clarithromycin and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a suspected soft-tissue tumor.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Clarithromycin; Diagnosis, Differential; Elbow Joint; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Soft Tissue Neoplasms; Treatment Outcome | 2020 |
Cutaneous mycobacterial spindle cell pseudotumor: a potential mimic of soft tissue neoplasms.
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Etanercept; Granuloma, Plasma Cell; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prednisone; Receptors, Tumor Necrosis Factor; Sarcoma; Scleroderma, Systemic; Skin Diseases; Soft Tissue Neoplasms | 2011 |